PowerPoint Chapter 11

advertisement

SURGICAL PATIENT -

PHARMACOLOGY

A L L E R G Y A N D R E S P I R A T O R Y M E D I C A T I O N S

Copyright © 2013, 2010, 2006, 2003,

2000, 1995, 1991 by Mosby, an imprint of Elsevier Inc.

1

RESPIRATORY SYSTEM

• Upper Respiratory System- filters and humidifies air that is inhaled

• Oral and nasal cavity, sinuses, pharynx, larynx, and trachea

• Lower Respiratory System- exchange oxygen and carbon dioxide between alveoli/blood

• Right and left bronchi, right and left lungs, bronchioles, and alveoli

Copyright © 2013, 2010, 2006, 2003,

2000, 1995, 1991 by Mosby, an imprint of Elsevier Inc.

2

CHAP 11 -ANTIHISTAMINES

• Action – histamine- chemical the body produces that causes an inflammatory response

• Compete with histamine for H

1 receptor sites to limit its effect on body organs and structures

• Limits vasodilation, capillary permeability, and swelling

• Limits acetylcholine release, which dries secretions in the bronchioles and gastrointestinal system

• Sedative effect on the CNS

Copyright © 2013, 2010, 2006, 2003,

2000, 1995, 1991 by Mosby, an imprint of Elsevier Inc.

3

ANTIHISTAMINES (CONT.)

• Uses

• Seasonal allergic rhinitis (SAR)

• Perennial allergic rhinitis (PAR)

• Perennial nonallergic rhinitis (PNAR)

• Relieve symptoms of allergic disorders

• Adjunctive therapy for anaphylaxis

• Sedation

Copyright © 2013, 2010, 2006, 2003,

2000, 1995, 1991 by Mosby, an imprint of Elsevier Inc.

4

ANTIHISTAMINES (CONT.)

• Adverse Reactions

• Changes in blood pressure, blurred vision

• Tachycardia, insomnia, dry mouth, nausea

• Restlessness, excitability, sedation, tinnitus

• Drug Interactions (CNS depressants – hypnotics, sedatives, depressant analgesics, alcohol increase the effect. )

Copyright © 2013, 2010, 2006, 2003,

2000, 1995, 1991 by Mosby, an imprint of Elsevier Inc.

5

ANTIHISTAMINES

Life span considerations

• Pediatrics:

• Infants and young children often have anticholinergic side/adverse effects

• Paradoxical reactions may occur: increased nervousness, confusion, or hyperexcitability

• Elderly

• More likely to develop side effects such as dizziness, syncope (fainting), confusion, and extrapyramidal reactions

6

ANTI-HISTAMINE DRUGS

First Generation – usually OTC, crosses blood-brain barrier, sedative effect

• Dimetapp, Chlor-Trimeton, Benadryl, Banophen,

Phernergan

Second Generation – most available by prescription, some OTC, rapid onset, do not cross blood-brain barrier, do not cause excessive sedation

Zyrtec, Periactin, Allegra, Allergra D, Claritin,

Claritin D

Copyright © 2013, 2010, 2006, 2003,

2000, 1995, 1991 by Mosby, an imprint of Elsevier Inc.

7

CHAPTER 16 -ANTIEMETICS

Action

Inhibit cholinergic nerve impulses to the vomiting center of the brain

• Agents act to redirect stimulation by stopping or reducing stimulation of the vomiting center

Uses

• Prevent and treat motion sickness or the nausea and vomiting that occur with surgery, anesthesia, and cancer treatment

Copyright © 2013, 2010, 2006, 2003,

2000, 1995, 1991 by Mosby, an imprint of Elsevier Inc.

8

ANTIEMETIC-ANTIVERTIGO AGENTS

(CONT.)

Adverse Reactions

• Drowsiness and drug tolerance with longterm therapy

• Anticholinergic reactions – dry mouth, stuffy nose, blurred vision, constipations, urinary retention

Drug Interactions

• CNS depressants increase the sedative effect of antiemetic medications.

Copyright © 2013, 2010, 2006, 2003,

2000, 1995, 1991 by Mosby, an imprint of Elsevier Inc.

9

ANTIEMETIC-ANTIVERTIGO AGENTS

(CONT.)

Lifespan considerations

Pediatric patients with acute illnesses are at special risk for adverse reactions (Reye syndrome)

Assessment – find out hx of allergies and medications

Diagnosis – what other considerations vomiting may indicate – nutrition, electrolyte imbalance

Planning – educate patient on sedation effect

Copyright © 2013, 2010, 2006, 2003,

2000, 1995, 1991 by Mosby, an imprint of Elsevier Inc.

10

ANTIEMETIC/ANTIVERTIGO AGENTS

Compazine

Reglan

Dramamine

Benadryl

Antivert

Marinol

Scopolamine transdermal patch

Zofran

11

SEDATIVE-HYPNOTIC MEDICATIONS

Action and Uses

• Sedative agent: relaxes the patient and reduces anxiety and MAY lead to sleep

• Hypnotic agent produces sleep in the patient

• They are used to relax patients and induce sleep before medical testing and surgical procedures; used to treat insomnia caused by mental and physical stress

Lorzepam (Ativan), Temazepam (Restoril),

Phenobarbital

Schedule IV controlled substances

Copyright © 2013, 2010, 2006, 2003,

2000, 1995, 1991 by Mosby, an imprint of Elsevier Inc.

12

SEDATIVE-HYPNOTIC

MEDICATIONS

• Adverse Reactions – “hangover” effect, impaired coordination, headache, muscle or joint pain

• Drug Interactions- increase sedative effects of CNS depressants, analgesics, anesthetics, tranquilizers

Copyright © 2013, 2010, 2006, 2003,

2000, 1995, 1991 by Mosby, an imprint of Elsevier Inc.

13

GASTRO-INTESTINAL

ANTI-CHOLINGERGICS

• Three major types of GI medications: restore and maintain the lining of the GI tract; decrease acidity and motility; exert laxative action on the colon

• Pre operative Medication – Tagamet Histamine 2 recepter antagonist decreases gastric acidity and volume

Copyright © 2013, 2010, 2006, 2003,

2000, 1995, 1991 by Mosby, an imprint of Elsevier Inc.

14

Ch 17 – Analgesics

Opiod & Non-Narcotic

Copyright © 2013, 2010, 2006, 2003,

2000, 1995, 1991 by Mosby, an imprint of Elsevier Inc.

15

OPIOIDS

Two Forms

• Natural: from opium (morphine and codeine)

• Synthetic: man-made in the hope they would not be as additive – useful for pain mgt and reversal effects of opiods – (hydrocodone, oxycodone)

Synthetic: man-made mad

Copyright © 2013, 2010, 2006, 2003,

2000, 1995, 1991 by Mosby, an imprint of Elsevier Inc.

16

OPIOIDS (CONT.)

Agonist

• Binds with the receptor(s) to activate and produce the maximum response of the individual receptor

Partial agonist

• Produces a partial response

Agonist-antagonist

• Acts as an agonist at one type of receptor and as a competitive antagonist at another type of receptor

Copyright © 2013, 2010, 2006, 2003,

2000, 1995, 1991 by Mosby, an imprint of Elsevier Inc.

17

OPIOIDS (CONT.)

Morphine

• Uses

• Acute care

• Hospice

Codeine, hydrocodone, oxycodone

• Uses

• Office or clinical setting

Hydromorphone

• Uses

• Severe pain unrelieved by morphine

Copyright © 2013, 2010, 2006, 2003,

2000, 1995, 1991 by Mosby, an imprint of Elsevier Inc.

18

WONG-BAKER FACES PAIN RATING

SCALE

Copyright © 2013, 2010, 2006, 2003,

2000, 1995, 1991 by Mosby, an imprint of Elsevier Inc.

19

PAIN (CONT.)

Tolerance

• The same amount of a drug produces a decreased effect over time

Dependence

• A state in which the body will show withdrawal symptoms if the drug is stopped or reduced

Addiction

• The uncontrollable need to have and use a drug for nonmedical reasons

Copyright © 2013, 2010, 2006, 2003,

2000, 1995, 1991 by Mosby, an imprint of Elsevier Inc.

20

NARCOTIC AGONIST ANALGESICS

Action

• Prevent pain perception in the central nervous system

• Produce analgesia, sleepiness, euphoria, unclear thinking, slow breathing, produce miosis, decreased peristalsis, reduced cough reflex, and hypotension

Uses

• Treat moderate to severe pain

Copyright © 2013, 2010, 2006, 2003,

2000, 1995, 1991 by Mosby, an imprint of Elsevier Inc.

21

NARCOTIC AGONIST ANALGESICS

(CONT.)

Adverse Reactions

• Bradycardia, slowed breathing

• Hypotension, fainting

• Anorexia, constipation

• Confusion, euphoria

• Dry mouth, vomiting

• Pruritus, skin rash

Copyright © 2013, 2010, 2006, 2003,

2000, 1995, 1991 by Mosby, an imprint of Elsevier Inc.

22

PATIENT-CONTROLLED ANALGESIA

• Used when a continuous infusion of opioids is required

• Pump is calibrated to ordered dose and frequency

• Patient is able to self-administer pain medication by pushing control button

• Pump can be programmed to deliver an hourly rate

Copyright © 2013, 2010, 2006, 2003,

2000, 1995, 1991 by Mosby, an imprint of Elsevier Inc.

23

NARCOTIC AGONIST ANALGESICS

(CONT.)

Drug Interactions

• Many drugs increase or decrease effects

Nursing Implications

Patient Teaching

Copyright © 2013, 2010, 2006, 2003,

2000, 1995, 1991 by Mosby, an imprint of Elsevier Inc.

24

NARCOTIC AGONIST-ANTAGONIST

ANALGESICS

Action

• Act on chemicals at specific nerve sites in the CNS, possibly in the limbic system

• Produce analgesia, euphoria, and respiratory and physical depression

Uses

• Relief of moderate to severe pain

• Presurgical anesthesia

• Active labor

Copyright © 2013, 2010, 2006, 2003,

2000, 1995, 1991 by Mosby, an imprint of Elsevier Inc.

25

NARCOTIC AGONIST-ANTAGONIST

ANALGESICS (CONT.)

Adverse Reactions

• Bradycardia or tachycardia

• Hypertension or hypotension

• Changes in mood, confusion, nervousness

• Blurred vision, dizziness, headache

• Weakness, nystagmus, syncope, tingling

• Tinnitus, tremor, unusual dreams

• Nausea, vomiting, dry mouth, constipation

Copyright © 2013, 2010, 2006, 2003,

2000, 1995, 1991 by Mosby, an imprint of Elsevier Inc.

26

NARCOTIC AGONIST-ANTAGONIST

ANALGESICS (CONT.)

Drug Interactions

• Caution with alcohol and CNS depressants

• Nursing Implications

• Patient Teaching

Copyright © 2013, 2010, 2006, 2003,

2000, 1995, 1991 by Mosby, an imprint of Elsevier Inc.

27

NONNARCOTIC CENTRALLY ACTING

ANALGESICS

Action

• Act at the level of the brain to control mild or moderate pain

Uses

• Mild to moderate pain

• Used in combination products for pain alone or when pain and fever are present

Copyright © 2013, 2010, 2006, 2003,

2000, 1995, 1991 by Mosby, an imprint of Elsevier Inc.

28

NONNARCOTIC CENTRALLY ACTING

ANALGESICS (CONT.)

Adverse Reactions

• Postural hypotension, dizziness

• Disorientation, euphoria, headache

• Light-headedness, minor visual disturbances

• Sleepiness, slurring of speech, weakness

• Skin rashes, stomach or abdominal pain

• Dry mouth, nausea, vomiting, chills

• Difficulty urinating, stuffy nose

Copyright © 2013, 2010, 2006, 2003,

2000, 1995, 1991 by Mosby, an imprint of Elsevier Inc.

29

NONNARCOTIC CENTRALLY

ACTING ANALGESICS (CONT.)

• Drug Interactions

• Nursing Implications

• Patient Teaching

Copyright © 2013, 2010, 2006, 2003,

2000, 1995, 1991 by Mosby, an imprint of Elsevier Inc.

30

SKELETAL MUSCLE RELAXANTS

• Action: reduce muscle tone and involuntary movement without loss of voluntary motor function

• Centrally acting or direct myotropic blocking

• Uses: relief of pain in musculoskeletal and neurologic disorders involving peripheral injury and inflammation; relief of spasticity in chronic conditions

• Table 18-2

Copyright © 2013, 2010, 2006, 2003,

2000, 1995, 1991 by Mosby, an imprint of Elsevier Inc.

31

SKELETAL MUSCLE RELAXANTS

(CONT.)

• Adverse reactions: symptoms

• Drug interactions: sedatives, narcotic analgesics, antianxiety agents, hypnotics, alcohol, general anesthetics, MAOIs, and tricyclics

• Cyclobenzaprine and orphenadrine: anticholinergic effects that interfere with antihypertensive activity of alpha-adrenergic blockers

Copyright © 2013, 2010, 2006, 2003,

2000, 1995, 1991 by Mosby, an imprint of Elsevier Inc.

32

SKELETAL MUSCLE RELAXANTS

(CONT.)

• Nursing implications: assessment, diagnosis, planning, implementation, and evaluation

• Patient and family teaching: administration considerations; avoiding activities requiring alertness; drug interactions; missed dosages; when to contact the health care provider; HS administration; storage and safety

Copyright © 2013, 2010, 2006, 2003,

2000, 1995, 1991 by Mosby, an imprint of Elsevier Inc.

33

Download